From February 22, 2024 to March 31, 2024, the company has repurchased 272,900 shares, representing 0.41% for CNY 8.99 million. With this, the company has completed the repurchase of 272,900 shares, representing 0.41% for CNY 8.99 million under the buyback announced on February 23, 2024.
Medprin Regenerative Medical Technologies Co., Ltd.
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.26 CNY | -1.06% | -0.17% | -5.24% |
May. 13 | Medprin Regenerative Medical Technologies Co., Ltd. Approves Board Appointments | CI |
May. 13 | Medprin Regenerative Medical Technologies Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.24% | 380M | |
+13.71% | 130B | |
-8.45% | 10.87B | |
-3.55% | 8.4B | |
+39.26% | 5.55B | |
-24.12% | 4.77B | |
+7.80% | 3.42B | |
-11.14% | 2.71B | |
-11.32% | 2.11B | |
-13.47% | 1.91B |
- Stock Market
- Equities
- 301033 Stock
- News Medprin Regenerative Medical Technologies Co., Ltd.
- Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.